1. Home
  2. DSS vs AIMD Comparison

DSS vs AIMD Comparison

Compare DSS & AIMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DSS
  • AIMD
  • Stock Information
  • Founded
  • DSS 1984
  • AIMD 1984
  • Country
  • DSS United States
  • AIMD United States
  • Employees
  • DSS N/A
  • AIMD N/A
  • Industry
  • DSS Containers/Packaging
  • AIMD Biotechnology: Pharmaceutical Preparations
  • Sector
  • DSS Consumer Discretionary
  • AIMD Health Care
  • Exchange
  • DSS Nasdaq
  • AIMD Nasdaq
  • Market Cap
  • DSS 7.3M
  • AIMD 8.5M
  • IPO Year
  • DSS N/A
  • AIMD N/A
  • Fundamental
  • Price
  • DSS $0.86
  • AIMD $0.59
  • Analyst Decision
  • DSS
  • AIMD
  • Analyst Count
  • DSS 0
  • AIMD 0
  • Target Price
  • DSS N/A
  • AIMD N/A
  • AVG Volume (30 Days)
  • DSS 19.0K
  • AIMD 1.3M
  • Earning Date
  • DSS 03-26-2025
  • AIMD 03-07-2025
  • Dividend Yield
  • DSS N/A
  • AIMD N/A
  • EPS Growth
  • DSS N/A
  • AIMD N/A
  • EPS
  • DSS N/A
  • AIMD N/A
  • Revenue
  • DSS $25,019,000.00
  • AIMD $40,633.00
  • Revenue This Year
  • DSS N/A
  • AIMD N/A
  • Revenue Next Year
  • DSS N/A
  • AIMD N/A
  • P/E Ratio
  • DSS N/A
  • AIMD N/A
  • Revenue Growth
  • DSS N/A
  • AIMD N/A
  • 52 Week Low
  • DSS $0.77
  • AIMD $0.40
  • 52 Week High
  • DSS $2.30
  • AIMD $3.10
  • Technical
  • Relative Strength Index (RSI)
  • DSS 46.46
  • AIMD 46.09
  • Support Level
  • DSS $0.85
  • AIMD $0.57
  • Resistance Level
  • DSS $0.97
  • AIMD $0.64
  • Average True Range (ATR)
  • DSS 0.07
  • AIMD 0.09
  • MACD
  • DSS 0.01
  • AIMD -0.02
  • Stochastic Oscillator
  • DSS 38.09
  • AIMD 10.62

About DSS DSS Inc.

DSS Inc is operating a business focused on Five operating segments Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. Currently operates five distinct business lines operate around the globe with primary operations in North America and Asia.

About AIMD Ainos Inc.

Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.

Share on Social Networks: